Clinical Trial Update: Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 trial assessing weight gain and tolerability of naltrexone and varenicline in smokers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Smoking

Drugs mentioned

• Naltrexone (Naltrexone)
• Varenicline (varenicline)

Snippet

Sponsor: Yale University | Conditions: Smoking, Nicotine Dependence | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2010-09-21